BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 3090400)

  • 1. Inappropriate major histocompatibility complex class II expression by thyroid follicular cells in thyroid autoimmune disease and by pancreatic beta cells in type I diabetes.
    Pujol-Borrell R; Todd I; Londei M; Foulis A; Feldmann M; Bottazzo GF
    Mol Biol Med; 1986 Apr; 3(2):159-65. PubMed ID: 3090400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class II major histocompatibility complex and organ specific autoimmunity in man.
    Foulis AK
    J Pathol; 1986 Sep; 150(1):5-11. PubMed ID: 2946837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune thyroid disease--a perspective.
    Volpé R
    Mol Biol Med; 1986 Feb; 3(1):25-51. PubMed ID: 2870410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression and regulation of MHC products in the endocrine and exocrine cells of the human pancreas.
    Pujol-Borrell R; Todd I; Doshi M; Gray D; Feldmann M; Bottazzo GF
    Clin Exp Immunol; 1986 Jul; 65(1):128-39. PubMed ID: 3098471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modulation of the expression of histocompatibility antigens in thyroid follicular cells and in the beta cells of the pancreas: implications in the pathogenesis of thyroid autoimmune diseases and type 1 diabetes mellitus].
    Lucas Martín A; Pujol-Borrell R; Foz Sala M
    Med Clin (Barc); 1986 Nov; 87(16):684-7. PubMed ID: 3099109
    [No Abstract]   [Full Text] [Related]  

  • 6. The interaction of MHC and Gm in liability to autoimmune thyroid disease.
    Nagataki S
    Mol Biol Med; 1986 Feb; 3(1):73-84. PubMed ID: 3007922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune endocrine diseases.
    De Baets MH
    Year Immunol; 1989; 4():264-75. PubMed ID: 2564710
    [No Abstract]   [Full Text] [Related]  

  • 8. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
    J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathyroidal MHC class II antigen expression and thyroid autoimmunity.
    Davies TF; Piccinini LA
    Endocrinol Metab Clin North Am; 1987 Jun; 16(2):247-68. PubMed ID: 3319584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-dependent destruction of thyroid isografts exposed to IFN-gamma.
    Frohman M; Francfort JW; Cowing C
    J Immunol; 1991 Apr; 146(7):2227-34. PubMed ID: 1900881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperinducibility of HLA class II expression of thyroid follicular cells from Graves' disease. A primary defect?
    Sospedra M; Obiols G; Babi LF; Tolosa E; Vargas F; Roura-Mir C; Lucas-Martin A; Ercilla G; Pujol-Borrell R
    J Immunol; 1995 Apr; 154(8):4213-22. PubMed ID: 7706756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease.
    Matsunaga M; Eguchi K; Fukuda T; Kurata A; Tezuka H; Shimomura C; Otsubo T; Ishikawa N; Ito K; Nagataki S
    J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptides presented in vivo by HLA-DR in thyroid autoimmunity.
    Muixí L; Alvarez I; Jaraquemada D
    Adv Immunol; 2008; 99():165-209. PubMed ID: 19117535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies.
    Lucas-Martin A; Foz-Sala M; Todd I; Bottazzo GF; Pujol-Borrell R
    J Clin Endocrinol Metab; 1988 Feb; 66(2):367-75. PubMed ID: 3276724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-thyroid epithelial cell (TEC)-reactive CD8+ T cell lines/clones derived from autoimmune thyroiditis lesions. They recognize self-thyroid antigens directly on TEC to exhibit T helper cell 1-type lymphokine production and cytotoxicity against TEC.
    Sugihara S; Fujiwara H; Niimi H; Shearer GM
    J Immunol; 1995 Aug; 155(3):1619-28. PubMed ID: 7543527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid cell MHC class II antigens: a perspective on the aetiology of autoimmune thyroid disease.
    Davies TF; Roman SH; Mackenzie WA; Goldsmith N; Dower SM; Piccinini LA
    Acta Endocrinol Suppl (Copenh); 1987; 281():13-20. PubMed ID: 3303789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathology of type 1 diabetes.
    Campbell IL; Harrison LC
    Mol Biol Med; 1990 Aug; 7(4):299-309. PubMed ID: 2233244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro regulation of human thyrocyte HLA-DR antigen expression.
    Weetman AP; Volkman DJ; Burman KD; Gerrard TL; Fauci AS
    J Clin Endocrinol Metab; 1985 Nov; 61(5):817-24. PubMed ID: 2995430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity.
    Fu Y; Nathan DM; Li F; Li X; Faustman DL
    J Clin Invest; 1993 May; 91(5):2301-7. PubMed ID: 8486790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.